Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Martin Marietta Materials Shares Boosted By Insider Buying

On a down day for the stock market generally, shares of quarry miner Martin Marietta Materials, Inc (NYSE:MLM) fared better than most, rising 1.6%.

Part of the reason for this may owe to continued insider buying by the folks who know the company best — company insiders. Case in point: Insider Monkey’s database shows that on May 29, company director Stephen Zelnak made a direct purchase of 15,000 Martin Marietta shares at an average price of $150.16 per share.

According to information publicly available on Insider Monkey, this was the fourth such acquisition that Zelnak has made in just the past week. In addition to his most recent, Zelnak’s purchases have included:

-105 shares acquired in a non-open market transaction, also on May 29, at a time when the shares were selling for $149.21 per share;

-10,500 shares bought directly on May 27 at $151.40 per share;

– and 5,650 shares bought directly on May 26, at $150.35 per share.

That’s enough to lift Zelnak’s stake in the company to 52,649 shares in all — a $7.9 million stake in the company, and more than twice the shares he owned just one week ago.

What does it mean to you?
As a quick glance at the company’s Yahoo! Finance page will tell you, Martin Marietta shares currently fetch only $149.38 apiece on the open market, which appears to suggest that outside investors now have an opportunity to follow the insider’s lead — and pay a bargain price to do it.

A closer look at the data, however, suggests that you may want to think twice before treading where Mr. Zelnak has already trod. Priced today north of 51 times trailing earnings, pegged for only 11% long-term earnings growth by the analysts who follow it, and paying a below-market dividend yield of just 1.1%, Martin Marietta shares don’t look like any great bargain by ordinary financial metrics.

Then again, that does beg the question: If all Zelnak sees are the same numbers that the rest of us are seeing… then why is he buying? (Or does he perhaps see something more)?


This $19 trillion industry could destroy the Internet
One bleeding-edge technology is about to put the World Wide Web to bed. And if you act quickly, you could be among the savvy investors who enjoy the profits from this stunning change. Experts are calling it the single largest business opportunity in the history of capitalism… The Economist is calling it “transformative”… But you’ll probably just call it “how I made my millions.” Don’t be too late to the party — click here for one stock to own when the Web goes dark.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!